Home LiteratureArticle Details
PMID: 15613692 Published · ppublish English Comment Editorial Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

CTLA-4 blockade: unveiling immune regulation.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·Vol. 23 ·No. 4 ·2005-02-01 ·Pages 662-4

Dranoff G

Abstract

暂无摘要

MeSH Terms
Antibodies, Monoclonal/adverse effects Antigens, CD Antigens, Differentiation/immunology Autoimmunity CTLA-4 Antigen Cancer Vaccines/immunology Humans Mannitol/analogs & derivatives,therapeutic use Melanoma/immunology,therapy Oleic Acids/therapeutic use
Chemicals
Antibodies, Monoclonal Antigens, CD Antigens, Differentiation CTLA-4 Antigen CTLA4 protein, human Cancer Vaccines Oleic Acids montanide ISA 51 Mannitol
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Dranoff Glenn
Article Info
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Abbr.
J Clin Oncol
ISSN
0732-183X
DOI
10.1200/JCO.2005.09.923
Published
2005-02-01
Epub
2004-00-21
Pages
662-4
Language
English
Region
United States
NLM ID
8309333
Subset
IM
Grants
NCI NIH HHS · CA092625 · United States
NCI NIH HHS · CA66996 · United States
NCI NIH HHS · CA74886 · United States
Corrections
CommentOn
PMID: 15613700
External Links
PubMed source DOI: 10.1200/JCO.2005.09.923 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2